MORGAN STANLEY

Position in ORKA — Oruka Therapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in ORKA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,267,178

-$1,338,837 QoQ

Shares Held

76,360

-56.5% QoQ

Ownership

0.115%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#82

of 254 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 87% Shared 0% None 13%

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,717,846,796 across 523 Biotechnology names. ORKA ranks #152 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	42,931,597	$2,407,174,637
2	VRTX	Vertex Pharmaceuticals Inc / Ma	3,242,139	$1,610,467,694
3	ROIV	Roivant Sciences Ltd.	42,592,905	$1,507,362,901
4	REGN	Regeneron Pharmaceuticals, Inc.	1,397,712	$871,529,332
5	MRNA	Moderna, Inc.	9,538,094	$667,952,718
6	ARGX	Argenx SE	643,123	$596,670,219
7	TECH	BIO-TECHNE Corp	6,374,717	$450,373,747
8	INCY	Incyte Corp	2,948,364	$334,226,536

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,267,178	76,360	-56.5%	Shares	Defined	2026-08-13
2026-03-31	$8,606,015	175,454	-15.8%	Shares	Defined	2026-05-15
2025-06-30	$2,335,354	208,328	-60.5%	Shares	Defined	2025-08-15
2025-03-31	$5,415,134	527,791	+30.0%	Shares	Defined	2025-05-15
2024-12-31	$7,872,300	405,998	+495.9%	Shares	Defined	2025-05-15
2024-09-30	$1,669,939	68,133	—	Shares	Defined	2025-05-14
2024-06-30 ABIO	—	650,000	+216566.7%	Shares	Defined	2024-08-14
2023-03-31 ABIO	—	300	+29900.0%	Shares	Defined	2023-05-15
2021-12-31 ABIO	—	1	-94.1%	Shares	Defined	2022-02-14
2021-09-30 ABIO	—	17	-100.0%	Shares	Defined	2021-11-15
2021-03-31 ABIO	—	40,744	+952.5%	Shares	Defined	2021-05-17
2020-12-31 ABIO	—	3,871	—	Shares	Defined	2021-02-16
2020-03-31 ABIO	—	0	—	Shares	Defined	2020-05-26
No filing history on record for this holder in this stock.